skip to Main Content

May 17, 2022
Treatment Action Group Mourns Urvashi Vaid, Celebrates Her Life and Legacy
Statement / Press
Treatment Action Group (TAG) today mourns the premature loss of transformative LGBTQ and AIDS activist Urvashi Vaid, formerly executive director of the National Gay and Lesbian Task Force (now the National LGBTQ Task Force) at the height of the U.S. AIDS crisis in the late 1980s and early 1990s, and…

May 16, 2022
Research Toward a Cure Trials
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry. Click the trial registry identifier numbers for a link to the full entry containing detailed information on the trial design, enrollment criteria, principal investigators and location(s).

April 20, 2022
Joint Statement from Leading HIV/AIDS and Viral Hepatitis Advocates regarding Manufacturer Action on the 340B Drug Pricing Program
Statement / Press
A group of six leading HIV/AIDS and viral hepatitis advocates today released the following joint statement regarding recent manufacturer action against the 340B Drug Pricing Program:

April 13, 2022
TAG Submission to WHO Public Hearing Regarding a New International Instrument on Pandemic Preparedness and Response
Letter / Comment
At the first of these two public hearings TAG submitted the following statement with six reasons why the new international instrument must explicitly acknowledge the right to science as a central guiding framework.

March 29, 2022
HIV Updates From CROI: The Good, the Bad, and the Long-Acting
Webinar / Presentation
On April 15 TAG presented, “HIV Updates From CROI: The Good, the Bad, and the Long-Acting.” This free webinar unpacked the most significant developments in HIV research presented at the Conference on Retroviruses and Opportunistic Infection (CROI), and what they mean for communities affected by HIV.

March 3, 2022
Talk About It with TAG: The Impact of Long COVID on People Living With HIV
Webinar / Presentation
On March 3, 2022, we presented the first “Talk About It with TAG” webinar. This series addresses the needs of community members by having open discussions with researchers and community experts on issues related to COVID-19 and HIV biomedical research.

February 28, 2022
2022 Pre- and Post-CROI Community HIV Cure Research Workshop
Webinar / Presentation
The 2022 Community HIV Cure Research Workshop took place virtually this year due to the ongoing COVID-19 pandemic. There were two sessions, the first on Tuesday February 8th and the second on Tuesday March 1st.

February 23, 2022
Mourning Paul Farmer, Honoring His Legacy
Statement / Press
TAG’s staff and board of directors are filled with grief at the premature death of Dr. Paul Farmer, who illuminated and changed our world with his combination of passion, intelligence, solidarity with the poor, and determined will for social justice.

February 15, 2022
Submission to the Office of the High Commissioner for Human Rights Input to HRC resolution 47/17
Letter / Comment
On February 9, TAG submitted this testimony to the Office of the High Commission for Human Rights (OHCHR) to inform its upcoming report to the Human Rights Council (HRC) on ‘human rights in the context of HIV/AIDS’ (HRC resolution 47/17).

December 22, 2021
Statement from TAG’s HIV Project on FDA’s Approval of Injectable Pre-Exposure Prophylaxis
Statement / Press
Treatment Action Group (TAG) welcomes and celebrates the U.S. Food and Drug Administration’s (FDA) approval of Apretude brand cabotegravir, the first injectable medication for use as pre-exposure prophylaxis (PrEP) to reduce the risk of HIV transmission.

December 16, 2021
2021 TAG Update
Publication
As we look forward to an end of an extremely challenging year—and past four years—we reflect on the remarkable resilience and impact of TAG, even and especially in these dark times.

December 1, 2021
Reflecting on the Past!! Celebrating the Future!
Webinar / Presentation
To commemorate the 33rd World AIDS Day, on December 1, 2021, Treatment Action Group in collaboration with the HIV Vaccine Trials Network, Southern AIDS Coalition, and Black AIDS Institute held this webinar to reflect on the past and celebrate the many successes and innovations in biomedical research.

November 11, 2021
Update on HIV Vaccine Research
Publication
Developing an HIV vaccine is a difficult scientific challenge, but remains a critical priority. This handout provides an update on HIV vaccine research and a summary of results from the efficacy trials that have been conducted to date, and it was developed in collaboration with the Black AIDS Institute, HIV…

October 26, 2021
HIV Research Advocacy Fact Sheet
Publication
HIV advocacy laid the foundation for much of the work we do today. This handout was developed in collaboration with the Black AIDS Institute, HIV Vaccine Trials Network, and Southern AIDS Coalition. The handout provides a summary of the history of HIV research advocacy and updates on new HIV advocacy…

October 26, 2021
New HIV Prevention Research Fact Sheet
Publication
HIV prevention research continues to rapidly evolve. The availability of pre-exposure prophylaxis (PrEP) has necessitated the development of new approaches to testing the efficacy of additional biomedical HIV prevention options. This handout was developed in collaboration with the Black AIDS Institute, HIV Vaccine Trials Network, and Southern AIDS Coalition. The…

Back To Top